Drawing for Serial No. 85707783

USPTO serial 85707783

Serial No. 85707783

Reviewed by CopyMark Law Group

Reg. 4327667Status 710
Filing date
Status date
Registration date
Apr 30, 2013
Examiner
SETTLES LEWIS, SHAILA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 85707783?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathleen T. Petrich

Kathleen T. Petrich Miller Nash Graham & Dunn LLP2801 Alaskan Way, Suite 300Pier 70Seattle, WA 98121

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory useSECTION 8 - CANCELLED—
005Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseasesSECTION 8 - CANCELLED—
010Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancer, infectious diseases, and immunological diseases; Medical diagnostic devices for analysis of body fluids and biopsies for patient stratificationSECTION 8 - CANCELLED—
042Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admissionSECTION 8 - CANCELLED—
044Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 6, 2019C8..CANCELLED SEC. 8 (6-YR)—
Apr 30, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 22, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 12, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 30, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 12, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 23, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 31, 2012ALIEASSIGNED TO LIE—
Dec 14, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Dec 14, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 14, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 14, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2012DOCKASSIGNED TO EXAMINER—
Aug 28, 2012MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Aug 27, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 23, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance